IMCL
Imclone Systems, Inc
Biopharmaceutical company focused on oncology research and the development of the cancer drug Erbitux; acquired by Eli Lilly in 2008
CUSIP: 45245W109HealthcareUS1 holder
Recent Activity
2008Q4
1 sell
-11.67M shares
Icahn Capital LPEXIT
-11.67M shares
Loading more activity...